You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Cholestyramine - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for cholestyramine and what is the scope of patent protection?

Cholestyramine is the generic ingredient in eight branded drugs marketed by Parke Davis, Ajanta Pharma Ltd, Alkem Labs Ltd, Ani Pharms, Epic Pharma Llc, Ivax Sub Teva Pharms, Par Pharm, Tagi, Teva, Upsher Smith Labs, Zydus Pharms, Teva Pharms, Chartwell Rx, Bristol Myers, and Apothecon, and is included in twenty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for cholestyramine. Fifteen suppliers are listed for this compound.

Drug Prices for cholestyramine

See drug prices for cholestyramine

Recent Clinical Trials for cholestyramine

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Eli Lilly and CompanyPhase 1
Loxo Oncology, Inc.Phase 1
Ain Shams UniversityPhase 4

See all cholestyramine clinical trials

Pharmacology for cholestyramine
Drug ClassBile Acid Sequestrant
Mechanism of ActionBile-acid Binding Activity

US Patents and Regulatory Information for cholestyramine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Sub Teva Pharms CHOLESTYRAMINE cholestyramine POWDER;ORAL 074771-001 Jul 9, 1997 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Chartwell Rx LOCHOLEST LIGHT cholestyramine POWDER;ORAL 074562-002 Aug 15, 1996 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Teva CHOLESTYRAMINE LIGHT cholestyramine POWDER;ORAL 074348-001 May 28, 1998 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Alkem Labs Ltd CHOLESTYRAMINE LIGHT cholestyramine POWDER;ORAL 211799-002 Oct 19, 2021 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Teva CHOLESTYRAMINE LIGHT cholestyramine POWDER;ORAL 074348-002 May 28, 1998 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Alkem Labs Ltd CHOLESTYRAMINE LIGHT cholestyramine POWDER;ORAL 211799-001 Oct 19, 2021 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Epic Pharma Llc CHOLESTYRAMINE LIGHT cholestyramine POWDER;ORAL 074558-001 Aug 15, 1996 AB RX No Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for cholestyramine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Parke Davis CHOLYBAR cholestyramine BAR, CHEWABLE;ORAL 071621-001 May 26, 1988 ⤷  Try a Trial ⤷  Try a Trial
Parke Davis CHOLYBAR cholestyramine BAR, CHEWABLE;ORAL 071739-001 May 26, 1988 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.